Perbandingan Karakteristik dan Luaran Maternal pada Unexpected Spektrum Placenta Akreta saat Pandemi Covid -19

https://doi.org/10.22146/jkr.87601

Ratnasari Dwi Cahyanti(1*), Julian Dewantiningrum(2), Besari Adi Pramono(3), Irene Astrid Larasati(4), Putri Sekar Wiyati(5)

(1) Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Diponegoro
(2) Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Diponegoro
(3) Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Diponegoro
(4) RS PKU Muhammadiyah Temanggung
(5) Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Diponegoro
(*) Corresponding Author

Abstract


Latar belakang: Pandemi COVID-19 mempengaruhi sistem pelayanan kesehatan di dunia. Kegawatan maternal yang diakibatkan oleh Spektrum Placenta Akreta (SPA) menjadi tantangan di bidang obstetri, khususnya dalam kinerja multidisplin tim dan dukungan sumber daya fasilitas kesehatan.


Tujuan: Membandingkan karakteristik dan luaran dari pasien dengan unexpected dan expected SPA saat pandemi COVID-19.


Metode: Desain penelitian secara cross-sectional. Pengambilan sampel kasus SPA secara consecutive sampling dari data rekam medis RSUP Dr. Kariadi, Semarang, pada periode 2020 – 2021.


Hasil dan Pembahasan: Limapuluh tiga dari 154 kasus (34,42%) merupakan unexpected SPA. Tidak terdapat perbedaan karakteristik yang meliputi umur, indeks massa tubuh, jumlah riwayat sectio cesarea, jumlah riwayat placenta previa, cara persalinan dan kerjasama tim. Jumlah perdarahan dan kebutuhan transfusi darah yang diberikan tidak terdapat perbedaan pada kedua kelompok. Terdapat risiko untuk Cesarean histerektomi pada unexpected SPA (adjusted OR 4,13 (1,31-55,02)). Case Fatality Rate (CFR) pada unexpeted 5,67%, sedangkan pada expected 0,9%. Pada kasus unexpexted SPA didapatkan 3 kasus dengan terkonfirmasi COVID-19 dan meninggal.


Kesimpulan: Tata kelola spektrum placenta akreta di RSUP Dr. Kariadi selama pandemi COVID-19 tidak terdapat perbedaan luaran maternal pada kasus unxpected dan expected dan didapatkan kualitas pelayanan optimal dengan CFR yang rendah.

Kata kunci: Spektrum Placenta Akreta (SPA), unxpected dan expected, pandemi COVID-19, luaran maternal


Full Text:

PDF


References

  1. Fonseca A, Ayres de Campos D. Maternal morbidity and mortality due to placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol [Internet]. 2021;72:84–91. Available from: https://doi.org/10.1016/j.bpobgyn.2020.07.011
  2. Boatin AA, Ngonzi J, Ganyaglo G, Mbaye M, Wylie BJ, Diouf K. Cesarean delivery in low- and middle-income countries: A review of quality of care metrics and targets for improvement. Semin Fetal Neonatal Med. 2021;26(1).
  3. El Gelany S, Mosbeh MH, Ibrahim EM, Mohammed M, Khalifa EM, Abdelhakium AK, et al. Placenta Accreta Spectrum (PAS) disorders: Incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: A prospective study. BMC Pregnancy Childbirth. 2019;19(1):1–8.
  4. Jauniaux E, Jurkovic D, Hussein AM, Burton GJ. New insights into the etiopathology of placenta accreta spectrum. Am J Obstet Gynecol. 2022;227(3):384–91.
  5. Ali H, Chandraharan E. Etiopathogenesis and risk factors for placental accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol [Internet]. 2021;72:4–12. Available from: https://doi.org/10.1016/j.bpobgyn.2020.07.006
  6. Yu FNY, Leung KY. Antenatal diagnosis of placenta accreta spectrum (PAS) disorders. Best Pract Res Clin Obstet Gynaecol [Internet]. 2021;72:13–24. Available from: https://doi.org/10.1016/j.bpobgyn.2020.06.010
  7. Lee PS, Kempner S, Miller M, Dominguez J, Grotegut C, Ehrisman J, et al. Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes. Gynecol Oncol Res Pract. 2017;4(1):1–11.
  8. Chandraharan E, Hartopp R, Thilaganathan B, Coutinho CM. How to set up a regional specialist referral service for Placenta Accreta Spectrum (PAS) disorders? Best Pract Res Clin Obstet Gynaecol [Internet]. 2021;72:92–101. Available from: https://doi.org/10.1016/j.bpobgyn.2020.07.007
  9. Erfani H, Fox KA, Clark SL, Rac M, Rocky Hui SK, Rezaei A, et al. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol [Internet]. 2019;221(4):337.e1-337.e5. Available from: https://doi.org/10.1016/j.ajog.2019.05.035
  10. Moynihan R, Sanders S, Michaleff ZA, Scott AM, Clark J, To EJ, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: A systematic review. BMJ Open. 2021;11(3):11–7.
  11. Mahendradhata Y, Andayani NLPE, Hasri ET, Arifi MD, Siahaan RGM, Solikha DA, et al. The Capacity of the Indonesian Healthcare System to Respond to COVID-19. Front Public Heal. 2021;9(July):1–9.
  12. Pacu I, Zygouropoulos N, Cristea AE, Zaharia C, Rosu GA, Matei A, et al. The Risk of Obstetrical Hemorrhage in Placenta Praevia Associated with Coronavirus Infection Antepartum or Intrapartum. Med. 2022;58(8):1–13.
  13. Jauniaux ERM, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. BJOG An Int J Obstet Gynaecol. 2019;126(1):e1–48.
  14. Mittal P, Suri J, Pruthi N, Pandey D, Bharti R. Comparison of placenta accreta spectrum disorders diagnosed in intrapartum and antepartum period— A three year experience in a tertiary referral unit of India. Eur J Obstet Gynecol Reprod Biol [Internet]. 2019;236:41–5. Available from: https://doi.org/10.1016/j.ejogrb.2019.03.001
  15. Aryananda RA, Nieto-Calvache AJ, Duvekot JJ, Aditiawarman A, Rijken MJ. Management of unexpected placenta accreta spectrum cases in resource-poor settings. AJOG Glob Reports [Internet]. 2023;3(2):100191. Available from: https://doi.org/10.1016/j.xagr.2023.100191
  16. Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and Neonatal Morbidity and Mortality among Pregnant Women with and without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175(8):817–26.
  17. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020 Sep;370.
  18. Bellos I, Pandita A, Panza R. Maternal and perinatal outcomes in pregnant women infected by SARS-CoV-2: A meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021;256:194–204.



DOI: https://doi.org/10.22146/jkr.87601

Article Metrics

Abstract views : 500 | views : 351

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Jurnal Kesehatan Reproduksi Indexed by:

 

 



SEKRETARIAT JURNAL KESEHATAN REPRODUKSI
Departemen Obstetri dan Ginekologi, FK-KMK, UGM/RS Dr. Sardjito
Jl. Kesehatan No. 1, Sekip Utara, Yogyakarta 55281
Tlp: (0274) 511329 / Faks: (0274) 544003
Email: jurnal.kesehatanreproduksi@ugm.ac.id
Cp: Dwi Astuti +6281802698043